Preoperative administration of Omega-3 fatty acids on postoperative pain and acute-phase reactants in patients undergoing Roux-en-Y gastric bypass : A randomized clinical trial
Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved..
BACKGROUND: The term "Immunonutrition" (IMN) describes the enteral administration of certain substrates with a theoretical immunomodulating function. From all the elements conforming these IMN formulas, Omega-3 fatty acids (O3FA) are hypothesized to be the most important component for immunomodulation, with increased anti-inflammatory and antioxidant effect.
PATIENTS AND METHODS: A prospective randomized clinical trial of all the patients undergoing laparoscopic Roux-en-Y gastric bypass was performed. Patients were randomly assigned into 2 groups: those patients receiving a preoperative balanced energy high-protein formula (Control Group) and those ones who received the same preoperative nutritional formula enriched with O3FA (Experimental Group). In both groups, there was a restriction to 900 Kcal/day. Nutritional intervention started 10 days before surgery and was maintained up to 8 h before the surgical act. Preoperative weight loss, postoperative pain, complications and acute phase reactants were investigated.
RESULTS: 40 patients were included in the study, 20 in each group. Preoperative excess weight loss (EWL) with the prescribed treatment was 10.6 ± 7.7% in Control Group and 14.1 ± 5.8% in the Experimental Group (p = 0.024). Mean postoperative pain was 25 ± 9.2 mm in Control group and 10,9 ± 4,4 mm in Experimental Group (p = 0.015). CRP determined 24 h after surgery was significantly lower in the Experimental Group than in the Control Group. There were not significant differences in complications, mortality or readmission rates between groups.
CONCLUSIONS: The use of a nutritional supplement enriched with O3FA is associated with a greater preoperative weight loss, reduced postoperative pain and decreased postoperative levels of C reactive protein.
Errataetall: | |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
---|---|
Enthalten in: |
Clinical nutrition (Edinburgh, Scotland) - 38(2019), 4 vom: 15. Aug., Seite 1588-1593 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ruiz-Tovar, Jaime [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 22.06.2020 Date Revised 12.02.2021 published: Print-Electronic ClinicalTrials.gov: NCT03010280 CommentIn: Clin Nutr. 2020 Apr;39(4):1301. - PMID 32139109 Citation Status MEDLINE |
---|
doi: |
10.1016/j.clnu.2018.07.026 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM287364178 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM287364178 | ||
003 | DE-627 | ||
005 | 20231225053838.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.clnu.2018.07.026 |2 doi | |
028 | 5 | 2 | |a pubmed24n0957.xml |
035 | |a (DE-627)NLM287364178 | ||
035 | |a (NLM)30097364 | ||
035 | |a (PII)S0261-5614(18)31228-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ruiz-Tovar, Jaime |e verfasserin |4 aut | |
245 | 1 | 0 | |a Preoperative administration of Omega-3 fatty acids on postoperative pain and acute-phase reactants in patients undergoing Roux-en-Y gastric bypass |b A randomized clinical trial |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.06.2020 | ||
500 | |a Date Revised 12.02.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a ClinicalTrials.gov: NCT03010280 | ||
500 | |a CommentIn: Clin Nutr. 2020 Apr;39(4):1301. - PMID 32139109 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved. | ||
520 | |a BACKGROUND: The term "Immunonutrition" (IMN) describes the enteral administration of certain substrates with a theoretical immunomodulating function. From all the elements conforming these IMN formulas, Omega-3 fatty acids (O3FA) are hypothesized to be the most important component for immunomodulation, with increased anti-inflammatory and antioxidant effect | ||
520 | |a PATIENTS AND METHODS: A prospective randomized clinical trial of all the patients undergoing laparoscopic Roux-en-Y gastric bypass was performed. Patients were randomly assigned into 2 groups: those patients receiving a preoperative balanced energy high-protein formula (Control Group) and those ones who received the same preoperative nutritional formula enriched with O3FA (Experimental Group). In both groups, there was a restriction to 900 Kcal/day. Nutritional intervention started 10 days before surgery and was maintained up to 8 h before the surgical act. Preoperative weight loss, postoperative pain, complications and acute phase reactants were investigated | ||
520 | |a RESULTS: 40 patients were included in the study, 20 in each group. Preoperative excess weight loss (EWL) with the prescribed treatment was 10.6 ± 7.7% in Control Group and 14.1 ± 5.8% in the Experimental Group (p = 0.024). Mean postoperative pain was 25 ± 9.2 mm in Control group and 10,9 ± 4,4 mm in Experimental Group (p = 0.015). CRP determined 24 h after surgery was significantly lower in the Experimental Group than in the Control Group. There were not significant differences in complications, mortality or readmission rates between groups | ||
520 | |a CONCLUSIONS: The use of a nutritional supplement enriched with O3FA is associated with a greater preoperative weight loss, reduced postoperative pain and decreased postoperative levels of C reactive protein | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a C reactive protein | |
650 | 4 | |a Immunonutrition | |
650 | 4 | |a Omega-3 fatty acids | |
650 | 4 | |a Postoperative pain | |
650 | 4 | |a Preoperative excess weight loss | |
650 | 4 | |a Sleeve gastrectomy | |
650 | 7 | |a Fatty Acids, Omega-3 |2 NLM | |
650 | 7 | |a C-Reactive Protein |2 NLM | |
650 | 7 | |a 9007-41-4 |2 NLM | |
700 | 1 | |a Blanca, Maria |e verfasserin |4 aut | |
700 | 1 | |a Garcia, Alejandro |e verfasserin |4 aut | |
700 | 1 | |a Gonzalez, Juan |e verfasserin |4 aut | |
700 | 1 | |a Gutierrez, Sonsoles |e verfasserin |4 aut | |
700 | 1 | |a Paniagua, Amalia |e verfasserin |4 aut | |
700 | 1 | |a Prieto, Maria Jose |e verfasserin |4 aut | |
700 | 1 | |a Ramallo, Luisa |e verfasserin |4 aut | |
700 | 1 | |a Llanos, Lucia |e verfasserin |4 aut | |
700 | 1 | |a Duran, Manuel |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical nutrition (Edinburgh, Scotland) |d 1982 |g 38(2019), 4 vom: 15. Aug., Seite 1588-1593 |w (DE-627)NLM08284366X |x 1532-1983 |7 nnns |
773 | 1 | 8 | |g volume:38 |g year:2019 |g number:4 |g day:15 |g month:08 |g pages:1588-1593 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clnu.2018.07.026 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 38 |j 2019 |e 4 |b 15 |c 08 |h 1588-1593 |